DK Sinopharma, Inc. (OTCBB: DKSP) (the “Company” or “DKSP”) successfully co-hosted the 2nd China Western Gynecological Diseases Research Forum along with China Physician Association Gynecology Branch and Shaanxi Pharmacology Academic Council. Many experts and scholars in gynecology attended the conference, including 146 gynecologists from large hospitals across China.
“We were pleased to host these conferences, which gathered experts and gynecologists from across China to discuss the research and development of the treatment of gynecological diseases”
On April 10, 2010, the Company also hosted the first China Western Gynecological Diseases Research Forum.
“We were pleased to host these conferences, which gathered experts and gynecologists from across China to discuss the research and development of the treatment of gynecological diseases,” said Professor Dongke Zhao, the founder and CEO of DKSP.
As Vice-Chairman of Shaanxi Pharmacology Academic Council, Professor Zhao is widely respected in the Chinese pharmaceutical industry. “In addition to promoting research and development, the Research Forum has been an important opportunity to demonstrate the leadership of DKSP in women’s healthcare.”
In this conference, gynecologists from different hospitals had an extensive communication and exchange regarding the clinical efficiency of Gynecologic Inflammation Relieving Capsule, one of the Company’s patented and National Medical Insurance covered products. They also shared their experiences of clinical medical use.
After the conference, all the experts and gynecologists visited the Company’s production plant in Yangling. The visit enhanced their understanding of DKSP’s entire production process, production normalization and special attention on drug’s therapeutic efficiency.
With the help of the Specialized Academic Promotion, sales of Gynecologic Inflammation Relieving Capsule increased 81% by the end of September, compared to the same period in 2009.
Source: DK Sinopharma, Inc.